Back to Search
STEPHEN TREON, MD,PHD
MD,PHD
Internal Medicine Physician
NPI: 1821092453Individual
Specialties, Licenses & Credentials
Rheumatology Physician
Internal Medicine — Rheumatology
Code: 207RR0500X
MD0000024711(TN)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD0000024711(TN)
Research & Publications (20)
Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.
PMID 19118065·Clin Cancer Res·2009
3-trial
Expression of regulatory genes for lymphoplasmacytic cell differentiation in Waldenstrom Macroglobulinemia.
PMID 19220283·Br J Haematol·2009
8-other
Comparative outcomes following CP-R, CVP-R, and CHOP-R in Waldenström's macroglobulinemia.
PMID 19362976·Clin Lymphoma Myeloma·2009
8-other
Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy.
PMID 19362978·Clin Lymphoma Myeloma·2009
8-other
Ophthalmologic techniques to assess the severity of hyperviscosity syndrome and the effect of plasmapheresis in patients with Waldenström's macroglobulinemia.
PMID 19362987·Clin Lymphoma Myeloma·2009
8-other
International prognostic scoring system for Waldenstrom macroglobulinemia.
PMID 19196866·Blood·2009
4-observational
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
PMID 19064987·J Clin Oncol·2009
8-other
Soluble CD27 is a faithful marker of disease burden and is unaffected by the rituximab-induced IgM flare, as well as by plasmapheresis, in patients with Waldenström's macroglobulinemia.
PMID 19362974·Clin Lymphoma Myeloma·2009
8-other
Update on treatment recommendations from the Fourth International Workshop on Waldenstrom's Macroglobulinemia.
PMID 19047284·J Clin Oncol·2009
6-review
Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia.
PMID 19015393·Blood·2009
3-trial
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.
PMID 18981296·Blood·2009
8-other
Advances in the biology and treatment of Waldenström's macroglobulinemia: a report from the 5th International Workshop on Waldenström's Macroglobulinemia, Stockholm, Sweden.
PMID 19362961·Clin Lymphoma Myeloma·2009
8-other
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180.
PMID 19506160·J Clin Oncol·2009
3-trial
Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.
PMID 18815290·Blood·2008
8-other
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia.
PMID 18537966·Br J Haematol·2008
8-other
Serum immunoglobulin free light chain correlates with tumor burden markers in Waldenstrom macroglobulinemia.
PMID 18452095·Leuk Lymphoma·2008
4-observational
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia.
PMID 18347188·Clin Cancer Res·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 141 OCOEE ST
COPPERHILL, TN 37317 - Phone
- (423) 496-4103
Quick Facts
- NPI
- 1821092453
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile